Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEGAFUR\URACIL for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where TEGAFUR\URACIL was used for Prostate cancer.

Most Reported Side Effects for TEGAFUR\URACIL

Side Effect Reports % Deaths Hosp.
Neutropenia 23 18.7% 6 0
Diarrhoea 15 12.2% 3 6
Nausea 14 11.4% 2 4
Decreased appetite 13 10.6% 4 5
Fatigue 13 10.6% 3 3
Thrombocytopenia 11 8.9% 6 1
Anaemia 10 8.1% 6 2
Cardiac failure 9 7.3% 2 8
Leukopenia 9 7.3% 4 0
Neuropathy peripheral 8 6.5% 0 0
Palmar-plantar erythrodysaesthesia syndrome 8 6.5% 0 1
Disease progression 7 5.7% 3 0
Febrile neutropenia 7 5.7% 3 1
Vomiting 7 5.7% 1 2
Cerebral infarction 6 4.9% 0 5

Other Indications for TEGAFUR\URACIL

Colon cancer (10) Colorectal cancer (9) Colorectal cancer metastatic (9) Product used for unknown indication (7) Rectal cancer (6) Adenocarcinoma of colon (5) Breast cancer metastatic (5) Lung neoplasm malignant (5)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

TEGAFUR\URACIL Full Profile All Prostate cancer Drugs TEGAFUR\URACIL Demographics TEGAFUR\URACIL Timeline